Argent BioPharma Limited (ASX:RGT)
Australia · Delayed Price · Currency is AUD 0.0540
+0.0040 (8.00%)
Jul 21, 2026, 4:10 PM AEST
Argent BioPharma Market Cap
Argent BioPharma has a market cap or net worth of 6 million as of July 21, 2026. Its market cap has decreased by -2.21% in one year.
Market Cap
6.00M
Enterprise Value
12.07M
Revenue
347.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.05
ChartMarket Cap Chart
Since September 28, 2012, Argent BioPharma's market cap has increased from 3.12M to 6.00M, an increase of 92.46%. That is a compound annual growth rate of 4.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 6.00M | 2.79% |
| Dec 31, 2025 | 5.84M | -36.74% |
| Dec 31, 2024 | 9.23M | -46.77% |
| Dec 29, 2023 | 17.33M | -45.96% |
| Dec 30, 2022 | 32.07M | -67.88% |
| Dec 31, 2021 | 99.85M | 123.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medical Developments International | 46.19M |
| Peak Processing | 23.92M |
| Vitura Health | 20.54M |
| IDT Australia | 13.68M |
| Epsilon Healthcare | 8.56M |
| ECS Botanics Holdings | 7.98M |
| Cann Group | 6.64M |
| Percheron Therapeutics | 4.57M |